Mr. Mark Rochester

Mr Rochester is the clinical lead for urology at Norfolk & Norwich University Hospital and has a special interest in treatments for Benign prostate enlargement including HOLEP, urolift, rezum, iTind and also aquablation, as well as robotic surgery. He has been involved in a number of clinical trials for new BPH treatments and is currently Chief Investigator for the CLEAR study, as well as actively recruiting to 2 further BPH trials. He is an honorary associate professor at Norwich Medical School and an associate editor for BPH at the Journal of Clinical Urology. To contact Mr Rochester please email: mark.rochester@nnuh.nhs.uk